Cargando…
Disruption of the association between drug transporter and actin cytoskeleton abolishes drug resistance in hypertrophic scar
Hypertrophic scar is characterized by the overgrowth of fibroblasts and often considered as a kind of benign skin tumor, thus chemotherapeutic drugs have been used to treat scars. In view of the similarity, this study aims to investigate whether drug resistance in cancer that contributes to the fail...
Autores principales: | Su, Linlin, Fu, Lanqing, Li, Yan, Yang, Fangfang, Zhang, Min, Hu, Dahai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356828/ https://www.ncbi.nlm.nih.gov/pubmed/27926506 http://dx.doi.org/10.18632/oncotarget.13734 |
Ejemplares similares
-
The Akt/FoxO/p27(Kip1) axis contributes to the anti‐proliferation of pentoxifylline in hypertrophic scars
por: Yang, Fangfang, et al.
Publicado: (2019) -
Simultaneous deactivation of FAK and Src improves the pathology of hypertrophic scar
por: Su, Linlin, et al.
Publicado: (2016) -
Induction of chondrogenesis in limb mesenchymal cultures by disruption
of the actin cytoskeleton
Publicado: (1984) -
Breast Cancer Selective Disruption of Actin Cytoskeleton by Diallyl Trisulfide
por: Hahm, Eun-Ryeong, et al.
Publicado: (2022) -
Extracellular vesicles from Lactobacillus druckerii inhibit hypertrophic scar fibrosis
por: Han, Fu, et al.
Publicado: (2023)